WallStreetZenWallStreetZen

NASDAQ: NBSE
Neubase Therapeutics Inc Stock Ownership - Who owns Neubase Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Neubase Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Symetryx Corp10% Owner2023-09-1850,000$1.19
$59.50kSell
Symetryx Corp10% Owner2023-09-15103,337$1.26
$130.20kSell
Symetryx Corp10% Owner2023-09-14129,108$1.44
$185.92kSell
Symetryx Corp10% Owner2023-09-113,376$1.44
$4.86kSell
Symetryx Corp10% Owner2023-09-08128,847$1.53
$197.14kSell
Symetryx Corp10% Owner2023-09-0774,852$1.80
$134.73kSell
Symetryx Corp10% Owner2023-09-0161,076$0.98
$59.73kBuy
Dietrich A. StephanFounder and CEO2023-08-0293,234$0.02
$2.05kBuy

1 of 1

NBSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBSE insiders and whales buy or sell their stock.

NBSE Shareholders

What type of owners hold Neubase Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orin Hirschman186.43%6,952,332$3.07MInsider
Jason Scott Slakter90.82%3,386,992$1.50MInsider
Ira A. Greenstein8.88%331,051$146.32kInsider
Symetryx Corp5.16%192,481$85.08kInsider
Dietrich A. Stephan3.68%137,278$60.68kInsider
Greenlight Capital Inc3.66%136,350$60.27kInstitution
Todd P. Branning2.26%84,200$37.22kInsider
Eric I. Richman1.95%72,707$32.14kInsider
Ubs Group Ag1.76%65,724$29.05kInstitution
Point72 Asset Management LP1.68%62,500$27.63kInstitution

1 of 3

NBSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBSE3.93%96.07%Net Selling
ATNF7.45%92.55%Net Buying
BPTH3.24%96.76%
QLGN0.87%99.13%
SPRC0.68%0.00%
View Top Biotech Stocks

Neubase Therapeutics Stock Ownership FAQ

Who owns Neubase Therapeutics?

Neubase Therapeutics (NASDAQ: NBSE) is owned by 12.34% institutional shareholders, 301.92% Neubase Therapeutics insiders, and 0.00% retail investors. Orin Hirschman is the largest individual Neubase Therapeutics shareholder, owning 6.95M shares representing 186.43% of the company. Orin Hirschman's Neubase Therapeutics shares are currently valued at $3.06M.

If you're new to stock investing, here's how to buy Neubase Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.